CUHK Leads the Combat against Cancers Prevalent in Asia

Report Post
Researchers at CUHK are tirelessly dedicating their efforts in developing ways of early detection, diagnosis, and treatment to battle cancers.

Standing at the forefront of cancer research in Asia, the Chinese University of Hong Kong (CUHK) is a leader in the combat against four most lethal and prevalent cancers in the region, including gastrointestinal, nasopharyngeal, lung and liver cancers.

CUHK has been pushing the research frontiers of these deadly diseases by synergizing its capacity, research strengths, and talent across multiple disciplines, resulting in a number of internationally recognized “world’s first” and ground-breaking discoveries in cancer research, as well as numerous accolades worldwide in recognition of the invaluable contributions provided by its researchers. The University’s academic impact is also reflected in the many notable publications of its scholars which are highly cited in academia.

According to the World Health Organization, cancer is the second leading cause of death globally. CUHK works with leading institutions and national cancer centers regionally and globally to advance cancer research and treatment. With an extended collaborative network and multi-disciplinary teams, CUHK is primed to assume a leading role and committed to upholding its strong track-record in cancer research and care, advancing its understanding of different cancers and translating scientific findings into meaningful clinical outcomes for cancer patients.

Please visit our webpage to gain insight into CUHK’s landmark discoveries and breakthroughs in the four Asian prevalent cancers.